.svg){kind=icon}
Cannabis products are available through many routes of administration, including inhalation, oral ingestion, sublingual use, and application to the skin. Topical cannabis products belong to the last category: they are applied directly to a specific area of the body rather than inhaled or swallowed.
For medical cannabis patients, this raises an important pharmacology question: what actually happens when cannabinoids are placed on the skin?
Unlike inhaled THC, which enters the bloodstream rapidly through the lungs, or oral THC, which travels through the digestive system and liver, topical cannabinoids are generally intended to interact primarily with the skin and nearby tissues.
Understanding this distinction can help patients better understand topical cannabinoids, cannabis skin products, and the difference between localized topical application and true transdermal delivery.
What Are Topical Cannabinoids?
Topical cannabinoids are formulations containing compounds such as THC, CBD, or other cannabinoids that are applied directly to the skin.
Common topical formats include:
- Lotions
- Creams
- Balms
- Salves
- Gels
- Ointments
These formulations typically combine cannabinoids with oils, waxes, moisturizers, or other ingredients that help distribute the product over the skin.
Unlike an edible or inhaled product, a conventional topical is generally designed for application to a particular area rather than whole-body cannabinoid exposure.
This localized approach is one of the defining characteristics of medical cannabis topicals.
The Skin Is More Than a Protective Covering
The skin is the body's largest organ and serves as a highly effective barrier between the internal body and the outside environment.
Its outermost layer, known as the stratum corneum, plays a particularly important role.
The stratum corneum consists of tightly arranged skin cells surrounded by lipids. This structure helps prevent excessive water loss while also limiting the entry of environmental substances.
For topical cannabinoid products, this barrier is important because cannabinoids do not simply pass freely from the surface of the skin into the bloodstream.
Instead, much of a conventionally applied cannabinoid may remain within the outer layers of the skin.
That characteristic is what helps distinguish topical administration from transdermal administration.
The Skin Has Its Own Endocannabinoid System
Cannabinoid pharmacology is not limited to the brain.
Components of the endocannabinoid system, or ECS, are also found throughout the skin.
Research has identified cannabinoid receptors, endocannabinoid signaling molecules, enzymes, and other cannabinoid-sensitive molecular targets within structures including:
- Keratinocytes
- Hair follicles
- Sebaceous glands
- Sensory nerve fibers
- Immune cells
The ECS appears to participate in several normal functions involving skin homeostasis.
Researchers are studying its potential involvement in processes such as inflammation, sensation, sebum production, skin-cell growth, and barrier function.
This does not mean that every cannabinoid topical has been proven to treat a particular skin condition. It does, however, provide a biological reason researchers continue investigating cannabinoids for dermatologic and localized applications.
How Do Topical Cannabinoids Interact With the Skin?
When a cannabinoid lotion or balm is placed on the skin, the formulation first contacts the stratum corneum.
Cannabinoids such as THC and CBD are lipophilic, meaning they dissolve readily in fats and oils.
Because the outer layers of skin contain lipids, cannabinoids can enter and accumulate within these layers.
From there, some cannabinoids may penetrate farther depending on several factors, including:
- Cannabinoid concentration
- Product formulation
- Carrier oils
- Skin hydration
- Application area
- Duration of contact
- Individual skin characteristics
- Use of penetration-enhancing ingredients
This variability is one reason two topical products containing the same labeled amount of THC or CBD may not behave identically.
The formulation matters as much as the cannabinoid concentration.
Topical Does Not Automatically Mean Transdermal
One of the most important distinctions in cannabis pharmacology is the difference between topical and transdermal administration.
A topical product is generally intended to act primarily at or near the area where it is applied.
A transdermal product is specifically designed to move an active compound across the skin barrier and toward systemic circulation.
This means:
Topical: surface and localized application
Transdermal: delivery through the skin toward the bloodstream
The terms sometimes appear interchangeably in cannabis marketing, but pharmacologically they are not the same.
Simply applying THC or CBD to the skin does not guarantee meaningful systemic cannabinoid absorption.
True transdermal delivery generally requires specialized formulation techniques designed to overcome the skin barrier.
Do Topical Cannabis Products Cause Intoxication?
Conventional topical products are generally not intended to produce the same systemic psychoactive effects associated with inhaled or oral THC.
The skin barrier limits how readily THC reaches systemic circulation from an ordinary topical formulation.
However, patients should avoid assuming that all skin-applied cannabis products behave identically.
Research has demonstrated that some cannabinoid formulations can produce measurable systemic absorption, particularly when products contain ingredients specifically intended to improve skin penetration.
The safest approach is to follow the product label and use the product according to the recommendations of a qualified physician.
Patients should also distinguish ordinary topicals from products specifically marketed or formulated for transdermal delivery.
CBD, THC, and Other Cannabinoids in the Skin
CBD has received considerable attention in dermatology research.
Laboratory and early clinical studies have investigated CBD in relation to processes involving inflammation, itching, sebaceous activity, skin-barrier function, and other dermatologic mechanisms.
THC and other cannabinoids have also been studied for their interactions with cannabinoid receptors and sensory pathways within the skin.
More recently, researchers have begun investigating cannabinoids such as CBG for potential dermatologic applications.
However, the research remains relatively young.
A 2025 systematic review examining cannabinoids in dermatology found some evidence of improvement in itching but did not find significant improvements across several other measured skin outcomes.
That is an important reminder that promising biological mechanisms do not automatically translate into proven clinical treatments.
What Factors Affect a Cannabis Topical?
The cannabinoid listed on the package is only one component of a topical formulation.
Other ingredients can significantly affect how the product spreads, remains on the skin, and interacts with the skin barrier.
Common formulation ingredients may include:
- Jojoba oil
- Shea butter
- Coconut-derived oils
- Avocado oil
- Waxes
- Botanical extracts
- Moisturizing agents
Some products may also contain ingredients specifically selected to increase penetration.
For patients comparing medical cannabis topicals, the total formulation therefore matters—not simply the number of milligrams listed on the container.
Localized Application and Medical Cannabis
One potential advantage of topical administration is the ability to apply a product directly to a particular area.
This is fundamentally different from routes such as inhalation or ingestion, which introduce cannabinoids into systemic circulation.
The localized nature of conventional topical products is why researchers continue investigating them for dermatologic and peripheral applications.
At the same time, patients should be cautious about broad therapeutic claims.
Research into cannabinoid-containing topicals continues to develop, and different formulations have not been studied equally.
A product containing THC or CBD should not be considered a substitute for conventional medical treatment of a skin condition without guidance from an appropriate healthcare professional.
Florida Medical Cannabis Topical Example
Florida medical cannabis patients can encounter topical products alongside other routes of administration at dispensaries.
One current example available through Green Dragon Florida is Le Remedie Extra Strength THC Pain Relief Lotion.
The product is listed as a topical lotion containing 450 mg total THC and includes ingredients such as jojoba oil, avocado oil, and shea butter.
Because this article focuses specifically on localized skin application, this type of lotion is a more relevant example than products intended primarily for inhalation, ingestion, or sublingual administration.
Inventory varies between Green Dragon Florida locations, so patients should confirm current availability at their preferred dispensary.
Patients should follow labeled directions and speak with their qualified physician regarding appropriate medical cannabis routes and products.
Topicals as Part of Cannabis Pharmacology
Cannabis pharmacology is strongly influenced by route of administration.
Consider how differently cannabinoids can behave:
Inhalation: rapid pulmonary absorption and rapid systemic exposure.
Oral administration: slower gastrointestinal absorption with substantial first-pass liver metabolism.
Sublingual administration: absorption through tissues beneath the tongue may provide a different onset profile.
Topical administration: primarily localized application involving the skin and nearby tissues.
Transdermal administration: specifically formulated to move cannabinoids through the skin toward systemic circulation.
These differences demonstrate why two cannabis products containing similar cannabinoid amounts may produce very different pharmacokinetic profiles.
The Bottom Line
Topical cannabinoids provide a unique route of medical cannabis administration because they are applied directly to the skin rather than swallowed or inhaled.
The skin contains components of the endocannabinoid system and other molecular targets that can interact with cannabinoids. At the same time, the stratum corneum forms a powerful barrier that limits how easily cannabinoids move deeper into the body.
As a result, conventional cannabis topicals are generally associated with localized application rather than predictable systemic cannabinoid exposure.
Research into THC, CBD, CBG, and other cannabinoids in dermatology continues to expand, but clinical evidence remains limited for many proposed uses.
Understanding the difference between topical and transdermal delivery—and paying attention to the complete formulation rather than cannabinoid milligrams alone—can help Florida medical cannabis patients better understand this developing area of cannabis pharmacology.